Chemistry new website

Site logo

News @ Warwick Chemistry

[c]

New Asthma drug candidate has completed phase 1 clinical trials


FX125L, a small molecule anti-inflammatory drug discovered by David Fox, has recently completed the first stage of clinical trials on way to becoming a new treatment for asthma and other inflammatory diseases. In collaboration with the Grainger group (Dept. of Medicine, Cambridge) and Funxional Therapeutics Ltd (Cambridge-based SME) the new molecule has been shown to have excellent properties in man, and will be starting phase 2 clinical trials in 2010. FX125L is a member of a new class of peptide mimetics recently reported in J. Med. Chem. http://dx.doi.org/10.1021/jm900133w.

Sun 17 January 2010, 17:28 | Tags: people publications Syn

Dave Haddleton and collaborators report on the Antibacterial Effects of Poly(2-(dimethylamino ethyl)methacrylate) against Selected Gram-Positive and Gram-Negative Bacteria

Dave Haddleton and collaborators report on the Antibacterial Effects of Poly(2-(dimethylamino ethyl)methacrylate) against Selected Gram-Positive and Gram-Negative Bacteria in Biomacromolecules. Antimicrobial coatings can reduce the occurrence of medical device-related bacterial infections. Poly(2-(dimethylamino ethyl)methacrylate) (pDMAEMA) is one such polymer that is being researched in this regard. The aims of this study were to (1) elucidate pDMAEMA’s antimicrobial activity against a range of Gram-positive and Gram-negative bacteria and (2) to investigate its antimicrobial mode of action. The methods used include determination of minimum inhibitory concentration (MIC) values against various bacteria and the effect of pH and temperature on antimicrobial activity. The ability of pDMAEMA to permeabilise bacterial membranes was determined using the dyes 1-N-phenyl-naphthylamine and calcein-AM. Flow cytometry was used to investigate pDMAEMA’s capacity to be internalized by bacteria and to determine effects on bacterial cell cycling. pDMAEMA was bacteriostatic against Gram-negative bacteria with MIC values between 0.1−1 mg/mL. MIC values against Gram-positive bacteria were variable. pDMAEMA was active against Gram-positive bacteria around its pKa and at lower pH values, while it was active against Gram-negative bacteria around its pKa and at higher pH values. pDMAEMA inhibited bacterial growth by binding to the outside of the bacteria, permeabilizing the outer membrane and disrupting the cytoplasmic membrane. By incorporating pDMAEMA with erythromycin, it was found that the efficacy of the latter was increased against Gram-negative bacteria. Together, the results illustrate that pDMAEMA acts in a similar fashion to other cationic biocides. http://dx.doi.org/10.1021/bm901166y

Mon 04 January 2010, 17:03 | Tags: publications Mat

Dave Haddleton and collaborators report on Modification of Thiol Functionalized Aptamers by Conjugation of Synthetic Polymers

Dave Haddleton and collaborators report on Modification of Thiol Functionalized Aptamers by Conjugation of Synthetic Polymers in Bioconjugate Chemistry. Aptamers are known for their short in vivo circulating half-life and rapid renal clearance. Their conjugation to poly(ethylene glycol) (PEG) is a way to improve their residence in the body. Two aptamers (AptD and AptF), having a disulfide protected thiol modification on the 3′ end, have been conjugated to maleimide activated PEGs of various molecular weights and structures (linear PEG20; branched PEG20 and 40; PolyPEG17, 40, and 60 kDa). The high yield coupling (70−80% in most of the cases) could be achieved using immobilized tris[2-carboxyethyl]phosphine hydrochloride (TCEP) as reducing agent at pH 4. The affinity of PEGylated AptD for its target was reduced by conjugation to linear PEG20 and branched PEG40, but not to branched PEG20 and PolyPEGs. This work demonstrates an alternative approach to PEGylation of aptamers, and that the effect of PEG on the affinity for the target varies according to the structure and conformation of the synthetic polymer. http://dx.doi.org/10.1021/bc900397s

Mon 04 January 2010, 17:00 | Tags: publications Mat

Older news
Page contact: Stefan Bon Last revised: Sun 17 Jan 2010
Back to top of page
 

Web site search

People search

News

News.